Immunovant
Chirag K. Bhagat, PharmD, currently serves as the Director of Medical Science Liaison at Immunovant, beginning in January 2025. Previously, Chirag held various leadership roles at bluebird bio from September 2018 to January 2025, including Director of Field Medical Affairs & Operations and Senior Medical Science Liaison in Gene Therapy. Prior experience includes serving as Senior Medical Science Liaison for Hematology/Oncology at Genoptix, Medical Science Liaison II at Baxalta, and Director of Medical Affairs at Antares Pharma, Inc. Chirag's career also features roles such as Senior Medical Director for Rare Diseases/Oncology at CONNEXION Healthcare, Medical Director at Saatchi & Saatchi Wellness, and multiple positions at Vox Medica and GSW Worldwide. Chirag began in the industry as a Post-Doctoral Fellow at Bristol-Myers Squibb after completing a Pharm.D. at the University of Michigan from 2004 to 2007.
This person is not in any teams
This person is not in any offices
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.